NCT00080158

Brief Summary

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for phase_2 depression

Timeline
Completed

Started Mar 2004

Typical duration for phase_2 depression

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2004

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2004

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 26, 2004

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2007

Completed
Last Updated

June 22, 2020

Status Verified

June 1, 2020

First QC Date

March 24, 2004

Last Update Submit

June 18, 2020

Conditions

Keywords

Dysthymic DisorderAdolescent

Interventions

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • At least one suicide attempt or interrupted attempt within the past 45 days
  • Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Johns Hopkins University

Baltimore, Maryland, 21287, United States

Location

New York University Child Study Center

New York, New York, 10016, United States

Location

Columbia University at the New York State Psychiatric Institute

New York, New York, 10032, United States

Location

Duke University Medical Center

Durham, North Carolina, 27705, United States

Location

University of Pittsburgh - Western Psychiatric Institute and Clinic

Pittsburgh, Pennsylvania, 15213, United States

Location

University of Texas, Southwestern Medical Center

Dallas, Texas, 75235, United States

Location

Related Publications (2)

  • Brent DA, Greenhill LL, Compton S, Emslie G, Wells K, Walkup JT, Vitiello B, Bukstein O, Stanley B, Posner K, Kennard BD, Cwik MF, Wagner A, Coffey B, March JS, Riddle M, Goldstein T, Curry J, Barnett S, Capasso L, Zelazny J, Hughes J, Shen S, Gugga SS, Turner JB. The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):987-996. doi: 10.1097/CHI.0b013e3181b5dbe4.

  • Stanley B, Brown G, Brent DA, Wells K, Poling K, Curry J, Kennard BD, Wagner A, Cwik MF, Klomek AB, Goldstein T, Vitiello B, Barnett S, Daniel S, Hughes J. Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1005-1013. doi: 10.1097/CHI.0b013e3181b5dbfe.

MeSH Terms

Conditions

DepressionSuicide, AttemptedDysthymic Disorder

Interventions

FluoxetineSertralineCitalopramEscitalopramBupropionMirtazapineVenlafaxine HydrochlorideLithiumCognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSuicideSelf-Injurious BehaviorDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PropylaminesAminesOrganic Chemicals1-NaphthylamineNaphthalenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPolycyclic CompoundsNitrilesBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPropiophenonesKetonesDibenzazepinesHeterocyclic Compounds, 3-RingCyclohexanolsHexanolsFatty AlcoholsAlcoholsPhenethylaminesEthylaminesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicLipidsMetals, AlkaliElementsInorganic ChemicalsMetals, LightMetalsBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Laurence Greenhill, MD

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2004

First Posted

March 26, 2004

Study Start

March 1, 2004

Study Completion

June 1, 2007

Last Updated

June 22, 2020

Record last verified: 2020-06

Locations